SCHEMBL20546008

SCHEMBL20546008

CNc1ncccc1C(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
POLB P06746 2/20 0.58
ATM Q13315 1/20 0.58
CNR2 P34972 1/20 0.56
TDP1 Q9NUW8 1/20 0.54
ALDH1A1 P00352 4/20 0.53
RAB9A P51151 2/20 0.53
HPGD P15428 1/20 0.53
MAP2K1 Q02750 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.49
PKM P14618 1/20 0.49
BDKRB1 P46663 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CFTR P13569 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5005730 0.83 HTT (0.43) KDM4EPOLBATMCNR2TDP1
SCHEMBL28000002 0.83 HTT (0.67) KDM4EALDH1A1RAB9AL3MBTL1TSHR
SCHEMBL12426304 0.83 CNR2 (0.60) KDM4EPOLBATMCNR2TDP1
SCHEMBL1375514 0.81 DHODH (0.64) KDM4ETDP1ALDH1A1RAB9AL3MBTL1
SCHEMBL12990441 0.81 KMT2A (0.46) KDM4ETDP1ALDH1A1RAB9AHPGD
SCHEMBL29712338 0.81 DHODH (0.64) KDM4ETDP1ALDH1A1RAB9AL3MBTL1
SCHEMBL11492008 0.81 KDM4E (0.54) KDM4EPOLBATMCNR2TDP1
SCHEMBL7737600 0.81 CNR2 (0.52) KDM4EPOLBATMCNR2TDP1
SCHEMBL11604345 0.81 CNR2 (0.49) KDM4EPOLBATMCNR2TDP1
SCHEMBL14575165 0.80 CNR2 (0.51) KDM4EPOLBCNR2TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025050016-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2025-03-06 WO disclosed
EP-3615514-B1 PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF AVIARA PHARMACEUTICALS INC (US) 2023-11-22 EP disclosed
CN-110914242-B Propionic acid derivatives and methods of use thereof 阿维亚拉药品有限公司 2023-07-25 CN disclosed
US-10875875-B2 Propionic acid derivatives and methods of use thereof AVIARA PHARMACEUTICALS, INC. (US) 2020-12-29 US disclosed
CN-110914242-A Propionic acid derivatives and methods of use thereof 阿维亚拉药品有限公司 2020-03-24 CN disclosed
EP-3615514-A2 PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF Aviara Pharmaceuticals, Inc. (US) 2020-03-04 EP disclosed
US-20180312523-A1 Propionic Acid Derivatives and Methods of Use Thereof AVIARA PHARMACEUTICALS, INC. (US) 2018-11-01 US disclosed
WO-2018201167-A2 PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF AVIARA PHARMACEUTICALS, INC. (US) 2018-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312523-A1 Propionic Acid Derivatives and Methods of Use Thereof ITGB3, ITGA1, ITGB5 KDM4E 4039/4885POLB 3782/4885ATM 4354/4885
US-10875875-B2 Propionic acid derivatives and methods of use thereof ITGB3, ITGA1, ITGB5 KDM4E 4039/4885POLB 3782/4885ATM 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.